Dr. Marty Makary

That is a basic new principle of transparency we need to adopt in the United States. When Paxlovid, just as an example, the antiviral used, made by Pfizer to treat COVID, when that came out, the government recommended that for everyone. They promoted it. It was one of the biggest public health campaigns of the last year and a half of the pandemic.

That is a basic new principle of transparency we need to adopt in the United States. When Paxlovid, just as an example, the antiviral used, made by Pfizer to treat COVID, when that came out, the government recommended that for everyone. They promoted it. It was one of the biggest public health campaigns of the last year and a half of the pandemic.

That is a basic new principle of transparency we need to adopt in the United States. When Paxlovid, just as an example, the antiviral used, made by Pfizer to treat COVID, when that came out, the government recommended that for everyone. They promoted it. It was one of the biggest public health campaigns of the last year and a half of the pandemic.

A study came out in the New England Journal of Medicine just a number of months ago that showed zero benefit in people under 65, none, zilch. The study, now studies go different ways and that's the way science is, but the study ended nearly two years prior. If you look at the actual tables, the results were, the study was done Why did the public not see it for nearly two years?

A study came out in the New England Journal of Medicine just a number of months ago that showed zero benefit in people under 65, none, zilch. The study, now studies go different ways and that's the way science is, but the study ended nearly two years prior. If you look at the actual tables, the results were, the study was done Why did the public not see it for nearly two years?

A study came out in the New England Journal of Medicine just a number of months ago that showed zero benefit in people under 65, none, zilch. The study, now studies go different ways and that's the way science is, but the study ended nearly two years prior. If you look at the actual tables, the results were, the study was done Why did the public not see it for nearly two years?

Because it didn't go their way. When the COVID vaccine booster goes their way, they tell you before anything's even published. Just a press release, and it's a CDC recommendation.

Because it didn't go their way. When the COVID vaccine booster goes their way, they tell you before anything's even published. Just a press release, and it's a CDC recommendation.

Because it didn't go their way. When the COVID vaccine booster goes their way, they tell you before anything's even published. Just a press release, and it's a CDC recommendation.

Yes. So this is the type of trial-level transparency we need. Yeah. And we've got to do it now, because otherwise we need better funding in academics. We need more civil discourse in medicine. We need less cancel culture. Yeah.

Yes. So this is the type of trial-level transparency we need. Yeah. And we've got to do it now, because otherwise we need better funding in academics. We need more civil discourse in medicine. We need less cancel culture. Yeah.

Yes. So this is the type of trial-level transparency we need. Yeah. And we've got to do it now, because otherwise we need better funding in academics. We need more civil discourse in medicine. We need less cancel culture. Yeah.

Yeah.

Yeah.

Yeah.

Yeah. So a buddy of mine, Will Bruin, just graduated from medical school at – I don't know if I should say that school, but it's in the South. And he basically said he got two hours of teaching on all of nutrition and cholesterol and lipoproteins, basically. And in those two hours, and he got eight hours on a bunch of nonsense that he can't, you know, the disparity is unbelievable.

Yeah. So a buddy of mine, Will Bruin, just graduated from medical school at – I don't know if I should say that school, but it's in the South. And he basically said he got two hours of teaching on all of nutrition and cholesterol and lipoproteins, basically. And in those two hours, and he got eight hours on a bunch of nonsense that he can't, you know, the disparity is unbelievable.

Yeah. So a buddy of mine, Will Bruin, just graduated from medical school at – I don't know if I should say that school, but it's in the South. And he basically said he got two hours of teaching on all of nutrition and cholesterol and lipoproteins, basically. And in those two hours, and he got eight hours on a bunch of nonsense that he can't, you know, the disparity is unbelievable.

The two hours on nutrition, he said it would have been better not to have those two hours because there was so much misinformation in him. All it was was HDL is good. Yeah, exactly. Go forth. Preach to the world. Check their total triglycerides. Turns out lipoprotein A and apoprotein B are very good predictors, at least better than the current old crude predictors. Yeah.

The two hours on nutrition, he said it would have been better not to have those two hours because there was so much misinformation in him. All it was was HDL is good. Yeah, exactly. Go forth. Preach to the world. Check their total triglycerides. Turns out lipoprotein A and apoprotein B are very good predictors, at least better than the current old crude predictors. Yeah.